Used in research as a potent inhibitor of N-myristoyltransferase (NMT), IMP-1088 shows promise in blocking the replication of certain viruses, particularly picornaviruses such as rhinovirus, which are responsible for the common cold. By inhibiting NMT, the compound prevents the virus from modifying its proteins, a critical step required for viral assembly and propagation. This makes IMP-1088 a valuable tool in antiviral studies and a potential candidate for developing broad-spectrum antiviral therapies. Its application remains primarily in preclinical research and drug discovery settings.